Efficacy of Setarud (IMOD™), a novel electromagnetically-treated multi-herbal compound, in mouse immunogenic type-1 diabetes

Archives of Medical Science

Volumn 6, Issue 5, 2010, Pages 663-669

  Mohseni Salehi Monfared, Seyed Sajad ^a,b   Habibollahzadeh, Ebad ^a   Sadeghi, Hooman ^a   Baeeri, Maryam ^a   Abdollahi, Mohammad ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant; Diabetes; IMOD ; Insulitis; Multiple low dose streptozotocin; Oxidative stress

Indexed keywords

HERBACEOUS AGENT; IMOD; INTERLEUKIN 1BETA; MYELOPEROXIDASE; SETARUD; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ELECTROMAGNETIC RADIATION; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS;

EID: 78349249729     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.17078     Document Type: Article

References (39)

1. rd edition, Lippincott Williams & Wilkins 2003; 383-98.
2. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005; 59: 365-73.
3. Kajbaf F, Mojtahedzadeh M, Abdollahi M. Mechanisms underlying stress-induced hyperglycemia in critically ill patients. Therapy 2007; 4: 97-106.
4. Mordes JP, Serreze DV, Greiner DL, Rossini AA. Animal models of autoimmune diabetes mellitus, In: Leroith D, Taylor SI, Olefsky JM. Diabetes mellitus: a fundamental and clinical text. 3rd edition, Lippincott Williams & Wilkins 2003; 430-40.
5. Skyler JS, Marks JB. Immune intervention, In: Leroith D, Taylor SI, Olefsky JM. Diabetes mellitus: a fundamental and clinical text. 3rd edition, Lippincott Williams & Wilkins 2003; 500-6.
6. Mohseni Salehi Monfared SS, Larijani B, Abdollahi M. Islet transplantation and antioxidant management: a comprehensive review. World J Gastroenterol 2009; 15: 1153-61.
7. Rydgren T, Sandler S. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin- 1β-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo. Eur J Endocrinol 2002; 147: 543-51.
8. Fukudome D, Matsuda M, Kawasaki T, Ago Y, Matsuda T. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice. Eur J Pharmacol 2008; 583: 164-9.
9. Sarkhail P, Rahmanipour S, Fadyevatan S, et al. Antidiabetic effect of phlomis anisodonta: Effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Pharmacol Res 2007; 56: 261-6.
10. Milani E, Nikfar S, Khorasani R, Zamani MJ, Abdollahi M. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comp Biochem Physiol C Toxicol Pharmacol 2005; 140: 251-5.
11. Abdollahi M, Salehnia A, Mortazavi S, et al. Antioxidant, antidiabetic, antihyperlipidemic, reproduction stimulatory properties and safety of essential oil of satureja khuzestanica in rat in vivo: A toxicopharmacological study. Med Sci Monit 2003; 9: 331-5.
12. Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biol Med 1996; 20: 463-6.
13. http://www.wipo.int/pctdb/en/wo.jsp?wo=2007087825&IA= WO2007087825&DISPLAY=DESC
14. Khorram-Khorshid HR, Novitsky YA, Abdollahi M, et al. Studies on potential mutagenic and genotoxic activity of Setarud (IMODTM). DARU 2008; 16: 223-8.
15. Hosseini-Tabatabaei A, Esmaily H, Rahimian R, et al. Benefit of nicorandil using an immunologic murine model of experimental colitis. Cent Eur J Biol 2009; 4: 74-85.
16. Takamura T, Ando H, Nagai Y, Yamashita H, Nohara E, Kobayashi K. Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes. Diabetes Res Clin Pract 1999; 44: 107-14.
17. Rabinovitch A, Suarez-Pinzon WL, Solensen O, Bleackley C. Inducible nitric oxide synthase (iNOS) in pancreatic islets of non-obese diabetic mice: identification of iNOS expressing cells and relationships to cytokines expressed in the islets. Endocrinology 1996; 137: 2093-9.
18. Hosseini-Tabatabaei A, Abdollahi M. Potassium channel openers and improvement of toxic stress: do they have role in the management of inflammatory bowel disease? Inflamm Allergy Drug Targets 2008; 7: 129-35.
19. Cameron MJ, Arreaza GA, Zucker P, et al. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol 1997; 159: 4686-92.
20. Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am J Pathol 1997; 147: 1193-9.
21. Cailleau C, Diu-Hercend A, Ruuth E, Westwood R, Carnaud C. Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic mice. Diabetes 1997; 46: 937-40.
22. Nicoletti F, Zaccone P, Di Marco R, et al. The effects of a nonimmunogenic form of murine soluble interferon-γ receptor on the development of autoimmune diabetes in the NOD mouse. Endocrinology 1996; 137: 5567-75.
23. Oberley LW. Free radicals and diabetes. Free Radic Biol Med 1988; 5: 113-24.
24. Kubisch HM, Wang J, Bray TM, Phillips JP. Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic β-cells against oxidative stress. Diabetes 1997; 46: 1563-6.
25. Xu B, Moritz JT, Epstein PN. Overexpression of catalase provides partial protection to transgenic mouse beta cells. Free Radic Biol Med 1999; 27: 830-7.
26. Teucher T, Obertreis B, Ruttkowski T, Schmitz H. Cytokine secretion in whole blood of healthy subjects following oral administration of Urtica dioica L. plant extract [German]. Arzneimittelforschung 1996; 46: 906-10.
27. Riehemann K, Behnke B, Schulze-Osthoff K. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF-kappaB. FEBS Lett 1999; 442: 89-94.
28. Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arch Med Sci 2008; 4: 285-92.
29. Farzami B, Ahmadvand D, Vardasbi S, Majin FJ, Khaghani S. Induction of insulin secretion by a component of Urtica dioica leave extract in perifused Islets of Langerhans and its in vivo effects in normal and streptozotocin diabetic rats. J Ethnopharmacol 2003; 89: 47-53.
30. Wenzig EM, Widowitz U, Kunert O, et al. Phytochemical composition and in vitro pharmacological activity of two rose hip (Rosa canina L.) preparations. Phytomedicine 2008; 15: 826-35.
31. Bandoniene D, Pukalskas A, Venskutonis PR, Gruzdiene D. Preliminary screening of antioxidant activity of some plant extracts in rapeseed oil. Food Research International 2000; 33: 785-91.
32. Williams CA, Harborne JB, Geiger H, Hoult JR. The flavonoids of Tanacetum parthenium and T. vulgare and their anti-inflammatory properties. Phytochemistry 1999; 51: 417-23.
33. Amirshahrokhi K, Dehpour AR, Hadjati J, Sotoudeh M, Ghazi-Khansari M. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice. Toxicology and Applied Pharmacology 2008; 232: 119-24.
34. Astaneie F, Afshari M, Mojtahedi A, et al. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 2005; 36: 376-8.
35. Radfar M, Larijani B, Hadjibabaie M, Rajabipour B, Mojtahedi A, Abdollahi M. Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; A randomized, double-blind placebo-controlled clinical trial. Biomed Pharmacother 2005; 59: 302-6.
36. Afshari M, Larijani B, Rezaie A, Mojtahedi A, et al. Ineffectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo-controlled clinical trial. Biomed Pharmacother 2004; 58: 546-50.
37. Larijani B, Afshari M, Astanehi-Ashgari F, et al. Effect of short-term carvedilol therapy on salivary and plasma oxidative stress parameters and plasma glucose level in type II diabetes. Therapy 2006; 3: 119-23.
38. Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm Allergy Drug Targets 2009; 8: 2-10.
39. Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arch Med Sci 2008; 4: 285-92.